Feasibility of Cardiac Rehabilitation Models in Kenya.
Journal
Annals of global health
ISSN: 2214-9996
Titre abrégé: Ann Glob Health
Pays: United States
ID NLM: 101620864
Informations de publication
Date de publication:
2022
2022
Historique:
entrez:
28
1
2022
pubmed:
29
1
2022
medline:
4
5
2022
Statut:
epublish
Résumé
Heart failure (HF), is a leading cause of cardiovascular morbidity and mortality in Sub-Saharan Africa. Cardiac rehabilitation (CR) is known to improve functional capacity and reduce morbidity associated with HF. Although CR is a low-cost intervention, global access and adherence rates to CR remain poor. In regions such as Western Kenya, CR programs do not exist. We sought to establish the feasibility CR for HF in this region by testing adherence to institution and home-based models of CR. One hundred participants with New York Heart Association (NYHA) class II and III HF symptoms were prospectively enrolled from a tertiary health facility in Western Kenya. Participants were non-randomly assigned to participate in one of two CR models based on their preference. Institution based cardiac rehabilitation (IBCR) comprised 36 facility-based exercise sessions over a period of 12 weeks. Home based cardiac rehabilitation (HBCR) comprised weekly pedometer guided exercise targets over a period of 12 weeks. An observational arm (OA) receiving usual care was also enrolled. The primary endpoint of CR feasibility was assessed based on study participants to adherence to at least 25% of exercise sessions. Secondary outcomes of change in NYHA symptom class, and six-minute walk time distance (6MWTD) were also evaluated. Data were summarized and analyzed as means (SD) and frequencies. Paired t-tests, Chi Square, Fisher's, and ANOVA tests were used for comparisons. Mean protocol adherence was greater than 25% in both CR models; 46% ± 18 and 29% ± 11 (P < 0.05) among IBCR and HBCR participants respectively. Improvements by at least one NYHA class were observed among 71%, 41%, and 54%, of IBCR, HBCR and OA participants respectively. 6MWTD increased significantly by a mean of 31 ± 65 m, 40 ± 55 m and 38 ± 71 m in the IBCR, HBCR and OA respectively (P < 0.05). IBCR and HBCR, are feasible rehabilitation models for HF in Western Kenya. Whereas improvement in functional capacity was observed, effectiveness of CR in this population remains unknown. Future randomized studies evaluating effect size, long term efficacy, and safety of cardiac rehabilitation in low resource settings such as Kenya are recommended.
Sections du résumé
BACKGROUND
Heart failure (HF), is a leading cause of cardiovascular morbidity and mortality in Sub-Saharan Africa. Cardiac rehabilitation (CR) is known to improve functional capacity and reduce morbidity associated with HF. Although CR is a low-cost intervention, global access and adherence rates to CR remain poor. In regions such as Western Kenya, CR programs do not exist. We sought to establish the feasibility CR for HF in this region by testing adherence to institution and home-based models of CR.
METHODS
One hundred participants with New York Heart Association (NYHA) class II and III HF symptoms were prospectively enrolled from a tertiary health facility in Western Kenya. Participants were non-randomly assigned to participate in one of two CR models based on their preference. Institution based cardiac rehabilitation (IBCR) comprised 36 facility-based exercise sessions over a period of 12 weeks. Home based cardiac rehabilitation (HBCR) comprised weekly pedometer guided exercise targets over a period of 12 weeks. An observational arm (OA) receiving usual care was also enrolled. The primary endpoint of CR feasibility was assessed based on study participants to adherence to at least 25% of exercise sessions. Secondary outcomes of change in NYHA symptom class, and six-minute walk time distance (6MWTD) were also evaluated. Data were summarized and analyzed as means (SD) and frequencies. Paired t-tests, Chi Square, Fisher's, and ANOVA tests were used for comparisons.
FINDINGS
Mean protocol adherence was greater than 25% in both CR models; 46% ± 18 and 29% ± 11 (P < 0.05) among IBCR and HBCR participants respectively. Improvements by at least one NYHA class were observed among 71%, 41%, and 54%, of IBCR, HBCR and OA participants respectively. 6MWTD increased significantly by a mean of 31 ± 65 m, 40 ± 55 m and 38 ± 71 m in the IBCR, HBCR and OA respectively (P < 0.05).
CONCLUSIONS
IBCR and HBCR, are feasible rehabilitation models for HF in Western Kenya. Whereas improvement in functional capacity was observed, effectiveness of CR in this population remains unknown. Future randomized studies evaluating effect size, long term efficacy, and safety of cardiac rehabilitation in low resource settings such as Kenya are recommended.
Identifiants
pubmed: 35087707
doi: 10.5334/aogh.3392
pmc: PMC8782083
doi:
Banques de données
ClinicalTrials.gov
['NCT02795936']
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
7Informations de copyright
Copyright: © 2022 The Author(s).
Déclaration de conflit d'intérêts
The authors have no competing interests to declare.
Références
Ann Intern Med. 1971 Nov;75(5):804-5
pubmed: 5122169
Circulation. 2007 May 22;115(20):2675-82
pubmed: 17513578
Ann Med Exp Biol Fenn. 1957;35(3):307-15
pubmed: 13470504
Med Sci Sports Exerc. 1982;14(5):377-81
pubmed: 7154893
Am J Prev Med. 2009 May;36(5):452-7
pubmed: 19362699
Glob Heart. 2017 Dec;12(4):323-334.e10
pubmed: 28302548
J Card Fail. 2018 Dec;24(12):833-834
pubmed: 30527333
Physiotherapy. 2012 Dec;98(4):277-86
pubmed: 23122432
Open Heart. 2016 Sep 14;3(2):e000463
pubmed: 27738516
BMJ. 2015 Sep 29;351:h5000
pubmed: 26419744
Cochrane Database Syst Rev. 2019 Jan 29;1:CD003331
pubmed: 30695817
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Nat Rev Cardiol. 2014 Oct;11(10):586-96
pubmed: 25027487
Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
J Am Coll Cardiol. 2015 Dec 8;66(22):2550-60
pubmed: 26653630
Glob Heart. 2016 Mar;11(1):97-107
pubmed: 27102027
Circ Res. 2013 Aug 30;113(6):646-59
pubmed: 23989710
Heart Lung. 2009 Mar-Apr;38(2):100-8
pubmed: 19254628
Cochrane Database Syst Rev. 2014 Jun 25;(6):CD007131
pubmed: 24963623
J Cardiopulm Rehabil Prev. 2017 Mar;37(2):103-110
pubmed: 28033166
JAMA. 2009 Apr 8;301(14):1439-50
pubmed: 19351941
Glob Heart. 2020 Feb 12;15(1):15
pubmed: 32489788
J Cardiopulm Rehabil Prev. 2009 Jul-Aug;29(4):241-7
pubmed: 19628988
Cochrane Database Syst Rev. 2017 Jun 30;6:CD007130
pubmed: 28665511